Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O; French Cryptococcosis Study Group..

PLoS Med. 2007 Feb;4(2):e21.

2.

Major role for amphotericin B-flucytosine combination in severe cryptococcosis.

Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O; French Cryptococcosis Study Group..

PLoS One. 2008 Aug 6;3(8):e2870. doi: 10.1371/journal.pone.0002870.

3.

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE.

Clin Infect Dis. 2000 Apr;30(4):710-8.

4.

Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.

Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F; French Cryptococcosis Study Group..

MBio. 2015 Jun 9;6(3):e00311. doi: 10.1128/mBio.00311-15.

5.

Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.

Dannaoui E, Abdul M, Arpin M, Michel-Nguyen A, Piens MA, Favel A, Lortholary O, Dromer F; French Cryptococcosis Study Group..

Antimicrob Agents Chemother. 2006 Jul;50(7):2464-70.

6.

Clinical characteristics and outcomes of patients with cryptococcal meningoencephalitis in a resource-limited setting.

Chayakulkeeree M, Wangchinda P.

J Med Assoc Thai. 2014 Mar;97 Suppl 3:S26-34.

PMID:
24772578
7.

Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.

Bratton EW, El Husseini N, Chastain CA, Lee MS, Poole C, Stürmer T, Weber DJ, Juliano JJ, Perfect JR.

Antimicrob Agents Chemother. 2013 Jun;57(6):2485-95. doi: 10.1128/AAC.01800-12.

8.
9.

Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy.

Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, Dellamonica P, Botterel F, Dromer F, Chêne G.

AIDS. 2006 Nov 14;20(17):2183-91.

PMID:
17086058
10.

Current approach to the acute management of cryptococcal infections.

Powderly WG.

J Infect. 2000 Jul;41(1):18-22. Review. No abstract available.

PMID:
11041709
12.

Cryptococcal meningoencephalitis diagnosed by blood culture.

Sivasangeetha K, Harish BN, Sujatha S, Parija SC, Dutta TK.

Indian J Med Microbiol. 2007 Jul;25(3):282-4.

13.

Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

Charlier C, Dromer F, Lévêque C, Chartier L, Cordoliani YS, Fontanet A, Launay O, Lortholary O; French Cryptococcosis Study Group..

PLoS One. 2008 Apr 16;3(4):e1950. doi: 10.1371/journal.pone.0001950.

14.

Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.

Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S.

J Med Assoc Thai. 2006 Jun;89(6):795-802.

PMID:
16850679
15.

Cryptococcosis in human immunodeficiency virus-infected children.

Gonzalez CE, Shetty D, Lewis LL, Mueller BU, Pizzo PA, Walsh TJ.

Pediatr Infect Dis J. 1996 Sep;15(9):796-800.

PMID:
8878224
16.

[Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].

Metta HA, Corti ME, Negroni R, Helou S, Arechavala A, Soto I, Villafañe MF, Muzzio E, Castello T, Esquivel P, Trione N.

Rev Argent Microbiol. 2002 Jul-Sep;34(3):117-23. Spanish.

PMID:
12415893
17.

Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.

Parisi A, Malfitano A, Bruno R, Calderon W, Sacchi P, Patruno SF, Filice G.

Mycoses. 1997 Oct;40(5-6):203-7.

PMID:
9476489
18.

Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.

McCarthy KM, Morgan J, Wannemuehler KA, Mirza SA, Gould SM, Mhlongo N, Moeng P, Maloba BR, Crewe-Brown HH, Brandt ME, Hajjeh RA.

AIDS. 2006 Nov 14;20(17):2199-206.

PMID:
17086060
19.

[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].

Alonso M, García F, Mallolas J, Soriano A, Ortega M, Miró JM, Gatell JM, Soriano E.

Med Clin (Barc). 1999 Mar 27;112(11):401-5. Spanish.

PMID:
10231771
Items per page

Supplemental Content

Support Center